These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37040914)

  • 1. Varenicline-induced drug eruption: case and review of the literature.
    Correia C; Fernandes S; Correia T; Soares-de-Almeida L; Filipe P
    Dermatol Online J; 2023 Feb; 29(1):. PubMed ID: 37040914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis caused by varenicline.
    Caro Gutiérrez D; Gómez de la Fuente E; Feltes Ochoa RA; López Estebaranz JL; Salamanca Santamaría FJ
    Int J Dermatol; 2014 Sep; 53(9):e401-2. PubMed ID: 24961830
    [No Abstract]   [Full Text] [Related]  

  • 3. Varenicline-induced acute generalized exanthematous pustulosis.
    Attili SK; Ferguson J
    Clin Exp Dermatol; 2009 Oct; 34(7):e362-3. PubMed ID: 19489858
    [No Abstract]   [Full Text] [Related]  

  • 4. Varenicline-induced acute generalized exanthematous pustulosis confirmed by patch testing.
    Özkaya E; Yazganoğlu KD; Kutlay A; Mahmudov A
    Contact Dermatitis; 2018 Jan; 78(1):97-99. PubMed ID: 29265452
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis caused by varenicline.
    Duparc A; Gosset P; Caron J; Lasek A; Modiano P
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1111-2. PubMed ID: 19175479
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varenicline-induced acute dystonic reaction: a case report.
    Uca AU; Kozak HH; Uguz F
    Gen Hosp Psychiatry; 2014; 36(3):361.e1-2. PubMed ID: 24576987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
    Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
    Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of varenicline for smoking cessation.
    Hays JT; Ebbert JO; Sood A
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline-associated acute renal failure.
    Bird ML; Vesta KS
    Ann Pharmacother; 2008 Dec; 42(12):1908-11. PubMed ID: 18984856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A manic episode in a 64-year-old man: an adverse effect of varenicline.
    Ahmed AI
    Gen Hosp Psychiatry; 2011; 33(2):200.e9-200.e11. PubMed ID: 21596218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
    Nakamura M; Oshima A; Fujimoto Y; Maruyama N; Ishibashi T; Reeves KR
    Clin Ther; 2007 Jun; 29(6):1040-56. PubMed ID: 17692720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline for smoking cessation: is it a heartbreaker?
    Hays JT
    CMAJ; 2011 Sep; 183(12):1346-7. PubMed ID: 21727229
    [No Abstract]   [Full Text] [Related]  

  • 17. Varenicline-induced coronary thrombosis.
    Kalayci A; Eren A; Kocabay G; Karabay CY; Gecmen C; Kirma C
    Ann Pharmacother; 2013 Dec; 47(12):1727-9. PubMed ID: 24259623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline].
    Sanz Sanz CL; Meyer García-Sipido E; Fuentes Ponte M; Del Nogal Sáez F
    Med Clin (Barc); 2014 Feb; 142(4):179-80. PubMed ID: 23706682
    [No Abstract]   [Full Text] [Related]  

  • 19. Varenicline: the risks of over-the-counter sales in Brazil.
    Zaparoli JX; Galduróz JC
    Braz J Psychiatry; 2013; 35(4):442-3. PubMed ID: 24402222
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
    Franck AJ; Sliter LR
    Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.